Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

被引：20

作者：

Georgakopoulos, Jorge R. ^{[1
]}

Felfeli, Tina ^{[2
,3
]}

Drucker, Aaron M. ^{[1
,3
,4
]}

Jo, Christine E. ^{[5
]}

Piguet, Vincent ^{[1
,4
]}

Yeung, Jensen ^{[1
,6
,7
,8
]}

机构：

[1] Univ Toronto, Dept Med, Div Dermatol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada

[4] Womens Coll Hosp, Toronto, ON, Canada

[5] Univ Ottawa, Fac Med, Ottawa, ON, Canada

[6] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[7] Prob Med Res Inc, Waterloo, ON, Canada

[8] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,Fifth Floor, Toronto, ON M5S 1B2, Canada

来源：

JAAD INTERNATIONAL | 2021年 / 4卷

关键词：

adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety;

D O I：

10.1016/j.jdin.2021.06.001

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：67 / 69

页数：3

共 50 条

[31] TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis
Weidinger, S.
Stoelzl, D.
Abraham, S.
Haufe, E.
Heratizadeh, A.
Werfel, T.
Schmitt, J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S236 - S236
[32] Real-world persistence with dupilumab among adults with atopic dermatitis
Silverberg, Jonathan I.
Guttman-Yassky, Emma
Gadkari, Abhijit
Kuznik, Andreas
Mallya, Usha G.
Mastey, Vera
Zhang, Haixin
Chen, Zhen
Chen, Cheng
Korotzer, Andrew
Sierka, Debra
Fenton, Miriam C.
Kaur, Mandeep
Jalbert, Jessica J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 40 - 45
[33] Real-World Efficacy and Safety of Dupilumab Use in Japanese Adult Patients with Atopic Dermatitis: A Single-Center, Retrospective, 104-Week, Observational Study
Ikegami, Tetsuharu
Igawa, Ken
DISEASES, 2025, 13 (02)
[34] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
Kosaka, Keiji
Uchiyama, Akihiko
Ishikawa, Mai
Watanabe, Goichi
Motegi, Sei-ichiro
EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (06) : 800 - 802
[35] Real-world effectiveness and safety of upadacitinib in Japanese patients with atopic dermatitis: a two-centre retrospective study
Keiji Kosaka
Akihiko Uchiyama
Mai Ishikawa
Goichi Watanabe
Sei-ichiro Motegi
European Journal of Dermatology, 2022, 32 : 800 - 802
[36] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
Berna-Rico, Emilio
Fiz-Benito, Esther
Busto-Leis, Jose Manuel
Servera-Negre, Guillermo
de Lucas-Laguna, Raul
Feito-Rodriguez, Marta
DERMATOLOGY, 2024, 240 (02) : 337 - 342
[37] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
Peng, Cong
Cao, Qiaozhi
Xiong, Feng
Xu, Hui
Li, Jie
MEDCOMM, 2024, 5 (10):
[38] Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records
Wang, Candice
Kraus, Christina N.
Patel, Krupa G.
Ganesan, Anand K.
Grando, Sergei A.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (02) : 253 - 256
[39] A 52 WEEKS RETROSPECTIVE STUDY OF DUPILUMAB TREATMENT FOR MODERATE TO SEVERE ATOPIC DERMATITIS IN KOREA: LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN REAL WORLD PRACTICE
Ahn, Jiyoung
Jang, Dong Hyek
Heo, Seok Jae
Lee, Dong Heon
Jung, Hye Jung
Park, Mi Yeon
Seo, Seoung Jun
ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 13 - 13
[40] Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
Wang, Yuyi
Jia, Ruiling
Hu, Qin
Tao, Xiao
He, Qi
Luo, Guangying
Xiong, Qiong
Zhang, Zhongyu
Xiao, Yujuan
Liu, Yi
FRONTIERS IN IMMUNOLOGY, 2024, 15

← 1 2 3 4 5 →